We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-1.49%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$1.38B
AUM Growth
-$139M
Cap. Flow
-$105M
Cap. Flow %
-7.62%
Top 10 Hldgs %
10.8%
Holding
1,026
New
99
Increased
30
Reduced
127
Closed
96

Sector Composition

Rank Sector Weight
1 Financials 67.24%
2 Technology 9.48%
3 Healthcare 9.22%
4 Industrials 4.19%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADRT.WS
676
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$15K ﹤0.01%
268,610
NOVVR
677
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$15K ﹤0.01%
211,587
-8,413
-4% -$1.06K
CLAS.WS
678
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$15K ﹤0.01%
200,000
EONR.WS
679
EON Resources Warrants
EONR.WS
$14K ﹤0.01%
+450,000
New +$59K
ASCAR
680
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
$14K ﹤0.01%
+200,000
New +$32K
MDGSW
681
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$14K ﹤0.01%
55,486
GOGN.WS
682
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$14K ﹤0.01%
59,250
PGRWW
683
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$14K ﹤0.01%
131,300
TGR.WS
684
DELISTED
Kimbell Tiger Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TGR.WS
$14K ﹤0.01%
+75,000
New +$16.9K
FOXWW
685
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$14K ﹤0.01%
283,117
-6,800
-2% -$453
CHAA.WS
686
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$14K ﹤0.01%
136,232
RMTI icon
687
PUT
Rockwell Medical
RMTI
$28M
$13K ﹤0.01%
+1,030
New +$27.2K
GHIXW
688
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$13K ﹤0.01%
+33,333
New +$19.8K
VSACW
689
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$13K ﹤0.01%
128,756
EFTRW
690
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$13K ﹤0.01%
67,334
-942
-1% -$255
JGGCR
691
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$13K ﹤0.01%
+74,988
New +$12.2K
TRCA.WS
692
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$13K ﹤0.01%
133,333
ACAQ.WS
693
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$13K ﹤0.01%
93,450
ADALW
694
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$13K ﹤0.01%
111,719
BMAQR
695
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
$13K ﹤0.01%
246,987
EPHYW
696
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$13K ﹤0.01%
166,666
PSAGW
697
DELISTED
Property Solutions Acquisition Corporation II Warrant
PSAGW
$13K ﹤0.01%
175,000
HIIIW
698
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$13K ﹤0.01%
207,731
OSTRW
699
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$13K ﹤0.01%
98,300
VENAR
700
DELISTED
Venus Acquisition Corporation Rights
VENAR
$13K ﹤0.01%
125,000

Similar funds

CVI Holdings's Q2 2022 Portfolio in Review

As of Q2 2022, CVI Holdings held 1,026 positions worth $1.38B, down 9.2% from $1.51B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

CVI Holdings withdrew a net $105M in Q2 2022, closing 96 positions and reducing 127 holdings. Its most notable exit was Spring Valley Acquisition Corp. Class A Ordinary Share, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 67% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.

Against the trend, CVI Holdings opened a new position in Seres Therapeutics worth $9.34M.

  • CVI Holdings's largest Q2 2022 buy was Seres Therapeutics: 136,141 shares worth $9.34M.
  • CVI Holdings added most to Ares Acquisition Corporation in Q2 2022, an estimated $2.45M increase.
  • CVI Holdings's biggest Q2 2022 reduction was 2seventy bio, cutting an estimated $9.41M.
  • CVI Holdings fully exited Spring Valley Acquisition Corp. Class A Ordinary Share in Q2 2022, selling an estimated $18.3M.
  • CVI Holdings's ten largest holdings make up 11% of its $1.38B portfolio in Q2 2022.
  • CVI Holdings opened 99 new positions and closed 96 in Q2 2022.
  • CVI Holdings's portfolio value fell 9.2% quarter-over-quarter to $1.38B.

Based on CVI Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.